Patents by Inventor Robert Slater

Robert Slater has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240115285
    Abstract: A surgical shaver having: an outer tube with at least one outer tube opening at a distal end and an outer hub at a proximal end, the outer hub being configured for attachment to a handpiece; an inner tube rotatably positioned in the outer tube, the inner tube having at least one inner opening at a distal end, a cutting edge at the inner opening for cooperating with the outer tube opening to cut tissue and an inner hub at a proximal end, the inner hub being configured for attachment to a handpiece drive means; an RFID tag affixed to the outer tube or the outer hub, the RFID tag storing information about the shaver; an outer magnet coupled to the outer tube or the outer hub; and an inner magnet coupled to the inner tube or the inner hub.
    Type: Application
    Filed: September 29, 2023
    Publication date: April 11, 2024
    Inventors: Robert Fugerer, Jefferey Slater, Troy Garrison
  • Publication number: 20230193386
    Abstract: A method of detecting circulatory nucleic acids from a transplanted tissue in a transplant recipient, the method comprising: amplifying circulatory nucleic acids from a transplanted tissue in a blood sample from the transplant recipient, and detecting amplification of a copy number deletion (CND) polymorphism from the transplanted tissue, and related methods for determining the status of a donor tissue transplanted into a recipient.
    Type: Application
    Filed: February 10, 2023
    Publication date: June 22, 2023
    Inventors: Howard Robert Slater, Damien Luis Bruno, Devika Ganesamoorthy
  • Publication number: 20200340054
    Abstract: A method of detecting circulatory nucleic acids from a transplanted tissue in a transplant recipient, the method comprising: amplifying circulatory nucleic acids from a transplanted tissue in a blood sample from the transplant recipient, and detecting amplification of a copy number deletion (CND) polymorphism from the transplanted tissue, and related methods for determining the status of a donor tissue transplanted into a recipient.
    Type: Application
    Filed: May 11, 2020
    Publication date: October 29, 2020
    Inventors: Howard Robert Slater, Damien Luis Bruno, Devika Ganesamoorthy
  • Publication number: 20170342492
    Abstract: A method of detecting circulatory nucleic acids from a transplanted tissue in a transplant recipient, the method comprising: amplifying circulatory nucleic acids from a transplanted tissue in a blood sample from the transplant recipient, and detecting amplification of a copy number deletion (CND) polymorphism from the transplanted tissue, and related methods for determining the status of a donor tissue transplanted into a recipient.
    Type: Application
    Filed: August 11, 2017
    Publication date: November 30, 2017
    Inventors: Howard Robert Slater, Damien Luis Bruno, Devika Ganesamoorthy
  • Publication number: 20160218650
    Abstract: The invention concerns the damping of torsional oscillations/vibrations, particularly during electrical power generation within a gas turbine such as a civil aviation engine. The method of the invention relies on actively generating compensating oscillations in a driveline of a system to actively damp undesirable oscillations existing in the system.
    Type: Application
    Filed: January 20, 2016
    Publication date: July 28, 2016
    Applicant: ROLLS-ROYCE plc
    Inventors: Chandana Jayampathi GAJANAYAKE, Amit Kumar GUPTA, Robert SLATER, Bikramjit BHANGU, Gilbert Hock Beng FOO, Don Mahinda VILATHGAMUWA
  • Publication number: 20140285121
    Abstract: The present disclosure is directed to a modulation scheme for driving a piezo element. In one embodiment, a device may comprise, for example, a piezo element, voltage rails and bridge circuitry. The bridge circuitry may be coupled between the piezo element and the voltage rails. The bridge circuitry may include at least signal sources configured to generate drive signals that cause the piezo element to generate mechanical movement while being coupled to at least one of the voltage rails. In the same or a different embodiment the bridge circuitry may further include comparators, the output of the comparators being usable to determine the resonant frequency of the piezo element. The operating frequency of the bridge circuitry may be configured based on the resonant frequency of the piezo element.
    Type: Application
    Filed: November 7, 2012
    Publication date: September 25, 2014
    Inventors: Laszlo Balogh, Daniel Robert Slater
  • Publication number: 20140234273
    Abstract: The present disclosure relates generally to tissue, including organ, transplantation. Taught herein is a genetic-based diagnostic assay to ascertain the status of a tissue transplantation procedure in a recipient based on a characterization of circulating or other cell free nucleic acid material. The instant disclosure enables kits, primers and protocols for ascertaining the status of a transplantation procedure.
    Type: Application
    Filed: October 5, 2012
    Publication date: August 21, 2014
    Applicant: Muroch Children Research Institute
    Inventors: Howard Robert Slater, Damien Luis Bruno, Devika Ganesamoorthy
  • Patent number: 8135598
    Abstract: Systems and methods for guaranteeing a Target Value of an account on any given Target Value Date. The investment profile of the account may be automatically adjusted to be more or less conservative based on the evolution of the contract with respect to its accumulation value and guarantee. Within broadly defined groups of allocation choices the owner has complete freedom to distribute the account value to individual choices within those groups. The risk profile of the investments may be contracted to change as the Target Value Date approaches.
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: March 13, 2012
    Assignee: Allianz Life Insurance Company of North America
    Inventors: Adam Michael Brown, Daniel Robert Slater
  • Publication number: 20110086347
    Abstract: The present invention relates generally to a method for identifying or distinguishing one type of cell from other cells within a population of cells. The present invention further provides the detection, monitoring and isolation of sub-populations cell types within a population of cells including a biological entity comprising such cell types. Kits, diagnostic agents and panels of nucleic acid probes for identifying and distinguishing cell types also form part of the present invention. The detection of particular cell types is based upon the use of a labelled probe that hybridizes to chromosomal DNA at the flanking sequences of a deletion. Alternatively two probes with distinguishable reporter molecules are used wherein only one probe is capable of hybridizing to chromosomal DNA in one cell type whereas both are capable of hybridizing to chromosomal DNA in another cell type. The methods are useful in the identification of cells with copy number variations, chromosomal deletions, additions or aberrations.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 14, 2011
    Applicant: MURDOCH CHILDRENS RESEARCH INSTITUTE
    Inventors: Damien Luis Bruno, Howard Robert Slater
  • Publication number: 20100106532
    Abstract: Systems and methods for guaranteeing a Target Value of an account on any given Target Value Date. The investment profile of the account may be automatically adjusted to be more or less conservative based on the evolution of the contract with respect to its accumulation value and guarantee. Within broadly defined groups of allocation choices the owner has complete freedom to distribute the account value to individual choices within those groups. The risk profile of the investments may be contracted to change as the Target Value Date approaches.
    Type: Application
    Filed: October 28, 2008
    Publication date: April 29, 2010
    Applicant: ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
    Inventors: ADAM MICHAEL BROWN, DANIEL ROBERT SLATER
  • Publication number: 20050177353
    Abstract: A discrete event simulation (DES) and method of model development provide affordable, accurate, pre-validated, reusable and portable models and simulations that capture the complexity, interdependencies and stochastic nature of the operations and support (O&S) of weapons systems. A model of the O&S problem is created based on a service use profile (SUP) that describes a logical structure of delivery, maintenance, deployment, testing policy, infrastructure and logistics constraints. That model is translated into a DES, preferably using a “toolkit” including common attributes for the weapons and pre-validated common blocks and sub-models that define higher level functionality. The DES calculates a time-based prediction of weapons availability, maintenance activities, and spare parts stock over a life cycle of the weapons system.
    Type: Application
    Filed: February 5, 2004
    Publication date: August 11, 2005
    Inventor: Robert Slater
  • Patent number: 6886685
    Abstract: A stationery article of manufacture for carrying one or more self-stick note pads in combination with one or more other items, such as, business cards, photo identification cards, credit cards, check books, calculators, personal digital assistants, a wireless e-mail reader, and other similar items for convenience.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: May 3, 2005
    Inventor: Robert Slater
  • Publication number: 20040011676
    Abstract: A stationery article of manufacture for carrying one or more self-stick note pads in combination with one or more other items, such as, business cards, photo identification cards, credit cards, check books, calculators, personal digital assistants, a wireless e-mail reader, and other similar items for convenience.
    Type: Application
    Filed: July 16, 2002
    Publication date: January 22, 2004
    Inventor: Robert Slater
  • Patent number: 4997847
    Abstract: The invention relates to phenylsulphonamidolkanoic acids which have thromboxane A.sub.2 receptor antagonist activity.
    Type: Grant
    Filed: August 22, 1988
    Date of Patent: March 5, 1991
    Assignees: Smith Kline & French Laboratories Limited, Boehringer Mannheim GmbH
    Inventors: Robert J. Ife, David G. Cooper, Robert A. Slater, Karlheinz Stegmeier, Ernst-Christian Witte
  • Patent number: 4981873
    Abstract: The present invention concerns compounds of the formula: ##STR1## where R.sub.1 is an alkyl or alkenyl radical containing up to 6 carbon atoms, a cycloalkyl radical containing 3 to 7 carbon atoms, an aralkyl, aralkenyl or aryl radical in which the aryl radical or moiety can be substituted one or more times by halogen, C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -alkoxy, hydroxyl, trifluoromethyl, cyano, nitro, amino, C.sub.1 -C.sub.6 -alkylamino, C.sub.2 -C.sub.12 -dialkylamino, C.sub.1 -C.sub.6 -acylamino, C.sub.1 -C.sub.16 -acyl, C.sub.1 -C.sub.6 -alkylsulphenyl, -sulphinyl or -sulphonyl or by azido, R.sub.2 is hydrogen atom or a C.sub.1 -C.sub.6 -alkyl, aralkyl, aralkenyl or acyl radical, A and B are saturated or unsaturated alkylene chains containing up to 10 carbon atoms which can be substituted one or more times by C.sub.1 -C.sub.
    Type: Grant
    Filed: June 23, 1989
    Date of Patent: January 1, 1991
    Assignee: Boehringer Mannheim GmbH
    Inventors: Ernst-Christian Witte, Karlheinz Stegmeier, Liesel Doerge, Robert A. Slater
  • Patent number: 4946842
    Abstract: The invention relates to phenyl dihydropyridazinone derivatives that have utility as cardiac stimulants. A compound of the invention is 6-[4-(N.sup.3 -benzyl-N.sup.2 -cyanoguanidino)phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone.
    Type: Grant
    Filed: June 30, 1986
    Date of Patent: August 7, 1990
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: William J. Coates, John C. Emmett, Robert A. Slater
  • Patent number: 4820819
    Abstract: This invention relates to (isopropyl and tertiary butyl-amino-2-hydroxypropoxy)phenyl-3[2H]-pyridazinones which have .beta.-adrenoceptor antagonist activity.
    Type: Grant
    Filed: March 20, 1987
    Date of Patent: April 11, 1989
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: Anthony M. Roe, William J. Coates, Robert A. Slater, Stephen P. Breukelman
  • Patent number: 4812573
    Abstract: The invention relates to a class of tetrahydroisoquinolinylalkanoic acids containing an aryl sulphonamide group which have activity as thromboxane A.sub.2 antagonists.
    Type: Grant
    Filed: June 27, 1988
    Date of Patent: March 14, 1989
    Assignee: SmithKline & French Laboratories, Ltd.
    Inventors: Graham J. Durant, Andrew D. Gribble, Robert A. Slater
  • Patent number: D916753
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: April 20, 2021
    Assignee: Cognitive Credit Limited
    Inventors: Robert Slater, Richard Wheeldon, Davide Vago
  • Patent number: D916847
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: April 20, 2021
    Assignee: Cognitive Credit Limited
    Inventors: Robert Slater, Davide Vago, Richard Wheeldon